Xilio Therapeutics Inc XLO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:35 PM EDT
2.46UNCH (UNCH)
Volume
19,281
52 week range
2.04 - 27.95
Loading...
  • Open2.55
  • Day High2.55
  • Day Low2.46
  • Prev Close2.46
  • 52 Week High27.95
  • 52 Week High Date11/16/21
  • 52 Week Low2.04
  • 52 Week Low Date06/15/22

Key Stats

  • Market Cap67.58M
  • Shares Out27.47M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-84.62

KEY STATS

  • Open2.55
  • Day High2.55
  • Day Low2.46
  • Prev Close2.46
  • 52 Week High27.95
  • 52 Week High Date11/16/21
  • 52 Week Low2.04
  • 52 Week Low Date06/15/22
  • Market Cap67.58M
  • Shares Out27.47M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-84.62

RATIOS/PROFITABILITY

  • EPS (TTM)-3.03
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-0.67
  • EBITDA (TTM)-79.632M
  • ROE (TTM)-715.19%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)6.74%

EVENTS

  • Earnings Date12/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xilio Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, including cytokines and other biologics, that are designed to enhance therapeutic index. Using its GPS platform, the Company is engaged in developing a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat...
Paul Clancy
Chairman of the Board
Rene Russo Pharm.D.
Chief Executive Officer, Director
Martin Huber M.D.
President
Joseph Farmer J.D.
Chief Operating Officer
Salvatore Giovine
Chief Financial Officer
Chris Frankenfield
General Counsel
Address
828 Winter Street, Suite 300
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
RPHM
Reneo Pharmaceuticals Inc
2.87+0.10+3.61%
SNSE
Sensei Biotherapeutics Inc
2.20-0.01-0.45%
EVAX
Evaxion Biotech A/S
2.92-0.01-0.46%
LTRN
Lantern Pharma Inc.
6.39UNCHUNCH
NMTR
9 Meters Biopharma Inc
0.2839+0.0148+5.50%